Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study
Joanna M. Biernacka, Brandon J. Coombes, Anthony Batzler, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2132-2139
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Genetics of substance use disorders: a review
Joseph D. Deak, Emma C. Johnson
Psychological Medicine (2021) Vol. 51, Iss. 13, pp. 2189-2200
Open Access | Times Cited: 49
Medications for treating alcohol use disorder: A narrative review
Henry R. Kranzler, Emily E. Hartwell
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 7, pp. 1224-1237
Closed Access | Times Cited: 17
The Genetically Informed Neurobiology of Addiction (GINA) model
Ryan Bogdan, Alexander S. Hatoum, Emma C. Johnson, et al.
Nature reviews. Neuroscience (2022) Vol. 24, Iss. 1, pp. 40-57
Closed Access | Times Cited: 27
Drug delivery strategies for the treatment of relapse behavior in substance use disorder- A systematic review
Megha Sihag, Manasi Varma, Ranjana Bhandari, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Deciphering the Role of Genetics in Alcohol Use Disorder
Evangelia Legaki, Ilias Koutromanos, Leonidas Mantonakis, et al.
(2025), pp. 1-34
Closed Access
Genetic liability for anxiety and treatment response to the monoamine stabilizer OSU6162 in alcohol dependence: a retrospective secondary analysis
Mun‐Gwan Hong, Lotfi Khemiri, Joar Guterstam, et al.
Pharmacological Reports (2025)
Open Access
Psychological and Clinical Parameters as Predictors of Relapse in Alcohol-Dependent Patients During and After Extensive Inpatient Rehabilitation Treatment
Josef Rábl, Dieter Geyer, Katharina M. Steiner, et al.
Brain Sciences (2025) Vol. 15, Iss. 4, pp. 374-374
Open Access
Pharmacogenomics polygenic risk score: Ready or not for prime time?
Sonal Singh, Gabriele Stocco, Katherine N. Theken, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 8
Open Access | Times Cited: 3
A randomized, double‐blind, placebo‐controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder
Chamindi Seneviratne, David A. Gorelick, Kevin G. Lynch, et al.
Alcoholism Clinical and Experimental Research (2022) Vol. 46, Iss. 10, pp. 1900-1912
Open Access | Times Cited: 15
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
Ming‐Fen Ho, Cheng Zhang, Lixuan Wei, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 13, pp. 3330-3345
Open Access | Times Cited: 14
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism
Ming‐Fen Ho, Cheng Zhang, Irene Moon, et al.
Molecular Metabolism (2022) Vol. 63, pp. 101534-101534
Open Access | Times Cited: 13
The genetic landscape of substance use disorders
Zachary F. Gerring, Jackson G. Thorp, Jorien L. Treur, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 11, pp. 3694-3705
Open Access | Times Cited: 2
EFFICACY OF MEDICATIONS FOR THE TREATMENT OF ALCOHOL USE DISORDER (AUD): A SYSTEMATIC REVIEW AND META-ANALYSIS CONSIDERING BASELINE AUD SEVERITY
Roberta Agabio, Hugo López‐Pelayo, Pol Bruguera, et al.
Pharmacological Research (2024) Vol. 209, pp. 107454-107454
Open Access | Times Cited: 2
Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities
Song Zhai, Devan V. Mehrotra, Judong Shen
Briefings in Bioinformatics (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 6
IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study
Ming‐Fen Ho, Cheng Zhang, James S. Cohan, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 304-314
Open Access | Times Cited: 1
Molecular mechanisms involved in alcohol craving, IRF3, and endoplasmic reticulum stress: a multi-omics study
Ming‐Fen Ho, Cheng Zhang, Irene Moon, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response
Svenja Müller, Klaus Lieb, Fabian Streit, et al.
Journal of Affective Disorders (2024) Vol. 363, pp. 542-551
Open Access | Times Cited: 1
Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder
Ming‐Fen Ho, Cheng Zhang, Irene Moon, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Post‐treatment effects of topiramate on alcohol‐related outcomes: A combined analysis of two placebo‐controlled trials
Henry R. Kranzler, Richard Feinn, Timothy Pond, et al.
Addiction Biology (2022) Vol. 27, Iss. 2
Open Access | Times Cited: 6
Neurobiology and the Treatment of Alcohol Use Disorder: A Review of the Evidence Base
Suzanna Donato, Lara A. Ray
Substance Abuse and Rehabilitation (2023) Vol. Volume 14, pp. 157-166
Open Access | Times Cited: 3
Epigenetic regulation of GABA catabolism in iPSC-derived neurons: The molecular links between FGF21 and histone methylation
Ming‐Fen Ho, Cheng Zhang, Irene Moon, et al.
Molecular Metabolism (2023) Vol. 77, pp. 101798-101798
Open Access | Times Cited: 2
RNA biomarkers for alcohol use disorder
Laura B. Ferguson, R. Dayne Mayfield, Robert O. Messing
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 3
Comparative pharmacogenetic study of disulfiram or cyanamide efficacy for alcohol dependence: the key role of dopamine neurotransmission gene polymorphisms
А.О. Кибитов, К. В. Рыбакова, V. M. Brodyansky, et al.
V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY (2024)
Open Access
Personality correlates of past-year alcohol use in individuals with severe alcohol use disorder and a lifetime history of involvement in Alcoholics Anonymous
Séverine Lannoy, Dace S. Svikis, Mallory Stephenson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Genetic liability for anxiety associates with treatment response to the monoamine stabilizer OSU6162 in alcohol dependence
Mun‐Gwan Hong, Lotfi Khemiri, Joar Guterstam, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top